Skip to content Skip to sidebar Skip to footer

Sanofi hopes AI will drive operational improvements

Sanofi hopes AI will drive operational improvements

French drugmaker Sanofi (Euronext: SAN) has placed a strong
emphasis on the adoption of artificial intelligence capabilities
to facilitate its internal operations.

The company is rolling out “plai,” a tool for Sanofi staff
developed with AI platform company Aily Labs.

The app is designed to deliver “real-time, reactive data
interactions,” Sanofi said, providing its employees with a
comprehensive view of the company’s activities.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.


Try before you buy

• All the news that moves the needle in pharma and biotech.
• Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
• Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

• Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
• Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
• Daily roundup of key events in pharma and biotech.
• Monthly in-depth briefings on Boardroom appointments and M&A news.
• Choose from a cost-effective annual package or a flexible monthly subscription.

Leave a comment